Guest: Timothy E. Albertson, MD, MPH, PhD

Unknown: Paul G. Auwaerter, MD, MBA

Like other viruses, SARS-CoV-2 evolves over time. Certain variants have gained widespread attention because of their rapid emergence within populations and evidence for transmission or clinical implications; per the CDC, these are considered variants of concern. Clinicians may be challenged to optimize use of COVID-19 vaccines and therapeutics in the clinical context of SARS-CoV-2 variants given the complex nature of the variants and the ever-evolving data surrounding them. Because of the significance associated with SARS-CoV-2 variants, clinicians require education on the latest data and clinical recommendations regarding these variants.